A case is described oflate pulmonary graft failure in a heart/lung transplant recipient. The major characteristics were alveolar fibrosis and a restrictive physiological deficit. Epstein-Barr virus was implicated as an aetiological agent using immunohistochemical analysis and by a response to treatment with ganciclovir. (Thorax 1996;51:1160- persistent pyrexia she was maintained on high dose oral prednisolone (1 mg/kg reduced by 5 mg per week), in addition to cyclosporin and azathioprine. An autoantibody screen was negative. A thoracic computed tomographic (CT) scan 16 weeks after transplantation demonstrated an acinar infiltrate suggestive of infection. Four consecutive bronchoalveolar lavages (BAL) and transbronchial biopsy failed to reveal an infective agent or evidence of aspiration but demonstrated progressive pulmonary fibrosis. In the presence of ongoing pyrexia and a restrictive physiological defect suggestive of bronchiolitis obliterans organising pneumonia (BOOP), she underwent a repeat CT scan followed by an open lung biopsy of the left lung (10 months after transplantation).
The major limiting factor to the long term success of lung transplantation is the development of obliterative bronchiolitis within the graft which presents as a predominantly obstructive physiological pattern associated with fibrosis and obliteration of the terminal bronchioles of the graft.' In contrast, we describe a female patient who developed graft failure with a pure restrictive physiological de . Sections were stained with the gp3401220-specific monoclonal antibody 72A1 and reactivity was observed using biotinylated rabbit anti-mouse and streptavidin-FITC as previously described.2 Serial sections from the same block were stained with isotype-matched control serum samples and were negative. The photomicrograph shows gp3401220-specific positive staining under ultraviolet illumination. Original magnification x 800. ganciclovir 10 mg/kg daily. Over one week her pyrexia resolved.
She was maintained on intravenous ganciclovir until the time of a single lung re-transplant 12 months after her first transplant. The explanted lung of the heart/lung block was reexamined after ganciclovir for the presence of gp340/220-specific staining and was entirely negative. The patient died four weeks later from graft failure, aspergillus infection, and renal failure.
Discussion
The commonest cause of graft failure following heart/lung transplantation is obliterative bronchiolitis.1 In our patient there were many features atypical of obliterative bronchiolitis and subsequent investigations, together with the therapeutic trial of ganciclovir, suggest that EBV infection may have been causal in the progressive graft fibrosis. The patient was febrile on presentation prior to augmented immunosuppression and this pyrexia persisted.
The acinar changes seen on the first CT scan indicated possible infection and this is a common cause of eosinophilic infiltration in a lung graft.4 Repeated investigations for potential infective organisms were undertaken and EBV replication within the graft tissue was the only organism identified. The recurrent pyrexia, documented for 28 weeks, was only eradicated ultimately with intravenous ganciclovir. This suggests that active EBV infection was responsible for the pyrexia and possibly the eosinophilic infiltration at the time ofpresentation. An additional finding which implies that EBV was pathogenic in this case was that, when the explanted lung tissue was re-examined after the pyrexia had lysed and following ganciclovir therapy, there was no evidence of EBV replication.
Obliterative bronchiolitis is considered to represent a manifestation of chronic graft rejection. It is typified histologically by scarring of membranous and respiratory bronchioles with obliteration of the bronchiolar lumen and fibro-intimal thickening of the arteries and veins within the graft.45 In our case the dominant feature was that of interstitial fibrosis ( fig  2) . Physiologically, obliterative bronchiolitis is characterised by progressive small airways obstruction. The physiological pattern in our patient was that of a pure restrictive defect. The typical radiological changes seen with obliterative bronchiolitis are those of hyperinflation and associated bronchiectasis. 6 The CT scans of our patient initially demonstrated acinar changes suggestive of infection which progressed in severity to confluent alveolar opacification located predominantly in the lower lobes (fig 1) without Augmented immunosuppression often leads to opportunistic infection. The finding of EBV within the lung tissue of this patient may therefore be viewed as representing passenger virus rather than a pathogen. Examples of this type of controversy are seen with cytomegalovirus (CMV) in the pulmonary tissue ofpatients with AIDS8 and human herpes virus 6 associated interstitial pneumonitis in bone marrow transplant patients.9 Although a number of features of this suggest that EBV may be pathogenic, it is important to note that, because of the presence of immunosuppression, it remains possible that the EBV replication was coincidental rather than causal to the graft failure.
The histological features of the open lung biopsy specimen suggest that neither obliterative bronchiolitis nor bronchiolitis obliterans organising pneumonia were the cause of the graft failure. The presence of pyrexia in association with an eosinophilic infiltrate, and the demonstration of EBV replication which responded to ganciclovir, implicates EBV in the aetiology of the graft failure. In view of this case and recent reports documenting EBV within lung graft tissue,'0 EBV may be an important occult pathogen in the setting of lung graft failure. Her respiratory condition gradually deteriorated and she developed cyclophosphamide related cystitis. She was accepted for a single lung transplant and placed on the waiting list in June 1992. At that stage she was receiving prednisolone 15 mg daily and her forced expiratory volume in one second (FEVI) was 1.06 1 (36% predicted), forced vital capacity (FVC) 1.17 1.
In April 1993 she underwent left single lung transplantation. The donor was a 28 year old female non-smoker with no history of cardiopulmonary disease. Total ischaemic time for the procedure was five hours. In the early postoperative period the patient required one course of methylprednisolone (1 g for three days) for acute rejection, and antibiotics for Staphylococcus aureus cultured from sputum. She made a complete recovery.
In April 1994 her exercise tolerance was excellent. She led a full active life and planned marriage. At her annual assessment FEV, was
